Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Plano, TX
SEC filing record 1 source field available
Fiscal year end
31 December
REATA PHARMACEUTICALS INC has filed 702 SEC EDGAR filings since 27 Mar 2006

SEC filing history

Showing 351-375 of 697 matching filings.

Per page
25
Current page
15
4

FORM 4 SUBMISSION

Filing date
15 Oct 2019
Reporting date
14 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Oct 2019
Reporting date
11 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K MOXIE PART 2 DATA

Filing date
15 Oct 2019
Reporting date
14 Oct 2019
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Oct 2019
Reporting date
10 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K_AMENDED AND RESTATED LICENSE AGREEMENT AND AMENDED LOAN AGREEMENT

Filing date
10 Oct 2019
Reporting date
09 Oct 2019
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Sep 2019
Reporting date
27 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
25 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2019
Reporting date
12 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
10 Sep 2019
Reporting date
06 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
29 Aug 2019
Reporting date
28 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
29 Aug 2019
Reporting date
28 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K - KHK FIFTH AND SIXTH SUPPLEMENT

Filing date
22 Aug 2019
Reporting date
22 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Aug 2019
Reporting date
15 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K

Filing date
08 Aug 2019
Reporting date
08 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Jul 2019
Reporting date
15 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Jun 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-232099

S-8

Filing date
13 Jun 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K 2019 ANNUAL MEETING RESULTS

Filing date
13 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .